Abstract
Lentiglobin Gene Therapy for Patients with Transfusion-Dependent β-Thalassemia (TDT): Results from the Phase 3 Northstar-2 and Northstar-3 Studies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have